Lepu Biopharma Co. Ltd. Class H's total assets for Q4 2024 were ¥2.28B, a decrease of 0.00% from the previous quarter. HK:2157 total liabilities were ¥1.60B for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.